CXCL2 and head and neck squamous cell carcinoma: Our findings underscore the pivotal role of chemokines in modulating radiosensitivity, highlighting the potential of CXCL2, CCL28, and CCR8 as predictive biomarkers for radiotherapy response in HNSCC patients.